Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Elan, Proteostasis team up for CNS drug and diagnostics development; ended

Executive Summary

Elan Corp. PLC and Proteostasis Therapeutics Inc. (focuses on maintaining protein balance) have teamed up for a five-year period to discover and develop disease-modifying small molecules and diagnostics for neurodegenerative disorders including Parkinson’s, Huntington’s, multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer’s, and other dementia-related conditions.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Includes Equity
    • R&D and Marketing (Licensing)

Related Companies